Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in

Dimitrios Davalos1, Jae Kyu Ryu, Mario Merlini

  • 1Gladstone Institute of Neurological Disease, University of California, San Francisco, 1650 Owens Street, San Francisco, CA 94158, USA.

Nature Communications
|November 29, 2012
PubMed

Insights

Fibrinogen, a blood protein, triggers early microglial immune responses near blood vessels, contributing to axonal damage in neuroinflammation. Blocking fibrinogen prevents this damage, revealing a key mechanism in multiple sclerosis.

Area of Science:

  • Neuroimmunology
  • Neuroinflammation
  • Multiple Sclerosis Pathogenesis

Background:

  • Multiple sclerosis involves blood-brain barrier disruption, microglial activation, and neurodegeneration.
  • The initial triggers for innate immune responses and their role in axonal damage are not fully understood.

Purpose of the Study:

  • To investigate the role of blood proteins in initiating microglial responses and axonal damage in neuroinflammation.
  • To identify specific triggers for early innate immune activation in the context of blood-brain barrier disruption.

Main Methods:

  • In vivo two-photon microscopy to observe microglial behavior in real-time.
  • Assessing the effects of fibrinogen on microglial clustering and reactive oxygen species release.
  • Utilizing anticoagulant treatment and genetic modification to block fibrinogen interactions.

Main Results:

  • Microglia form perivascular clusters prior to myelin loss or paralysis onset.
  • Fibrinogen specifically induces rapid and sustained microglial responses in vivo.
  • Fibrinogen leakage correlates with axonal damage and triggers reactive oxygen species release from microglia.
  • Inhibition of fibrin formation or fibrinogen-CD11b/CD18 interaction prevents microglial clustering and axonal damage.

Conclusions:

  • Early perivascular microglial clustering, triggered by fibrinogen leakage, contributes significantly to axonal damage in neuroinflammatory diseases.
  • Fibrinogen acts as a crucial initiator of innate immune responses at the vasculature in neuroinflammation.
  • Targeting fibrinogen or its receptor interactions may offer therapeutic strategies for neuroinflammatory conditions.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Inflammation01:38

Inflammation

Overview